Transplantation in Hematology and Oncology II

Cellular Therapy: Targets and Effectors.- Adoptive Immunotherapy in Chimeras.- The Roles of the Chemokine SDF-1 and its Receptor CXCR4 in Human Stem Cell Migration and Repopulation of NOD/SCID and B2mnull NOD/SCID mice.- Towards Adoptive Immunotherapy Using High Affinity T Cell Receptors.- New Antigens and Avenues to Immunotherapy of Cancer.- Allogeneic Cell Therapy with Antigen-Specific Cytotoxic T Lymphocytes (CTL) for Malignant Melanoma.- New Conditioning Strategies n Allogeneic Stem Cell Transplantation.- Intensification of the Conditioning Regimen for Patients with high-risk AML and MDS: 3 year Experience of using an188 Re -- Labelled anti -- CD 66 Monoclonal Antibody.- Dose Reduced Conditioning for Allogeneic Blood Stem Cell Transplantation from Sibling and Unrelated Donors in 51 Patients.- Pharmacokinetics of Conditioning Regimens.- Megadose Stem Cell Transplantation.- HD-Ara-C in the Conditioning Regimen for BMT in Acute Leukemias.- TBI-Based Reduced Intensity Conditioning with Allogeneic Hematopoietic Stem Cell Transplantation (SCT) in Patients with High-Risk Hematologic Malignancies.- Total Marrow Irradation (TMI), Busulfan, and Cyclophos-phamide for Allografting in Multiple Myeloma. A Pilot Study.- Stem Cell Mobilisation, Processing and Characteristics.- A "Single" Delayed Application of G-CSF after Autologous Peripheral Blood Stem Cell Transplantation -- A Pilot Study.- Factors Influencing PBPC Mobilisation and Collection in Haematological Malignancies.- Successful Purging of Stem Cell Products Using CD34 Selection.- Autologous Transplantation of Non-Cryopreserved HSCs in Oncologic Patients with Poor Prognosis: First Experience in the Ukraine.- A Randomized Comparison of Once Versus Twice Daily rhG-CSF (Filgrastim) for Stem Cell Mobilisation in Healthy Donors for Allogeneic Transplantation.- CD 133/CD34 Expression on Hematopoietic Stem-/ Progenitor Cells and Acute Leukemic Blasts.- Identification of Minimal Residual Leukemia Applying Continuous Gating.- Cord Blood Transplantation.- Pilot Study -- Lymphocyte Subset Reconstitution after Cord Blood Transplantation.- Altered Growth Characteristics of Cord Blood after in vivo Exposure of the Mother to Chemotherapy.- Mismatched Donor Transplantation.- Bone Marrow Transplantation from Mismatched Unrelated Donors.- Immune Reconstitution after Haploidentical Stem Cell Transplantation.- Clinical Transplantation -- Hematologic Malignancies.- Autografting and Allografting for Chronic Lymphocytic Leukemia: Is there a Rationale?.- Results of Stem Cell Transplantation in Children with CML in Comparison with Treatment with Cytostatics alone or with Interferon alfa. Report of the Polish Children's Leukemia/Lymphoma Study Group.- Comparison of Allogeneic Matched Related Stem Cell Transplantation in 1st CR with Chemotherapy alone in Children with High-Risk AML.- Stem Cell Transplantation in Acute Myeloid Leukemia after Conditioning with Busulfan, Cyclophosphamide and Different Dosages of Etoposide (VP-16).- The Occurrence of Acute Graft-Versus-Host Disease and Infectious Complications in Patients with Acute and Chronic Myeloid Leukemia who Underwent Allogeneic Peripheral Blood Stem Cell Transplantation.- Long-Term Survival after Stem Cell Transplant in Adult Acute Lymphoblastic Leukemia.- Clinical Transplantation -- Solid Tumors.- Autologous Transplantation in Breast Cancer in Europe and EBMT Data.- First-Line and Salvage High-Dose Chemotherapy in Patients with Germ-Cell Tumors.- High Dose Chemotherapy in High-Risk Ewing Tumours: Results in 156 (EI)CESS Patients.- Rapid Sequence Tandem Transplant in Children with High-Risk Neuroblastoma.- Anti-Angiogenesis.- Angiogenesis Inhibitor TNP-470 During Bone Marrow Transplant and in Minimal Residual Disease.- Challenges in the Treatment of Fungal Infections.- Prophylaxis of Fungal Infections in Neutropenic Patients with Hematologic Malignancies.